Diversity in Oncology Clinical Trials: Current Landscape for Industry-Sponsored Clinical Trials in Asia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Diversity in Oncology Clinical Trials: Current Landscape for Industry-Sponsored Clinical Trials in Asia ; volume:12 ; number:1 ; day:8 ; month:12 ; year:2023 ; pages:115-129 ; date:3.2024
Oncology and Therapy ; 12, Heft 1 (8.12.2023), 115-129, 3.2024
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Habr, Dany
Singh, Manmohan
Uehara, Roberto
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40487-023-00254-3
- URN
-
urn:nbn:de:101:1-2404291417320.511891418559
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Habr, Dany
- Singh, Manmohan
- Uehara, Roberto
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical trials in oncology
Trends in federally sponsored clinical trials
Phase I Clinical Trials in Oncology
Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Outcome differences by sex in oncology clinical trials
The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
Reporting outcome comparisons by sex in oncology clinical trials
Discontinuation and nonpublication of clinical trials in orthopaedic oncology
Quality assurance of investigator initiated clinical trials in oncology
Challenges in launching multinational oncology clinical trials in India
Clinical trials in oncology
Trends in federally sponsored clinical trials
Phase I Clinical Trials in Oncology
Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Outcome differences by sex in oncology clinical trials
The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
Reporting outcome comparisons by sex in oncology clinical trials
Discontinuation and nonpublication of clinical trials in orthopaedic oncology
Quality assurance of investigator initiated clinical trials in oncology
Challenges in launching multinational oncology clinical trials in India
Clinical trials in oncology
Trends in federally sponsored clinical trials
Phase I Clinical Trials in Oncology
Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Outcome differences by sex in oncology clinical trials
The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
Reporting outcome comparisons by sex in oncology clinical trials
Discontinuation and nonpublication of clinical trials in orthopaedic oncology
Quality assurance of investigator initiated clinical trials in oncology